Filing Details
- Accession Number:
- 0001455244-10-000091
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-05 13:00:00
- Reporting Period:
- 2010-04-01
- Filing Date:
- 2010-04-05
- Accepted Time:
- 2010-04-05 17:00:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
72444 | Nabi Biopharmaceuticals | NABI | Biological Products, (No Disgnostic Substances) (2836) | 591212264 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1459477 | W. Matthew Kalnik | 8610 Fernwood Road Bethesda MD 20817 | Svp Strategic Plan. & Bus. Ops | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-04-01 | 24,000 | $0.00 | 53,650 | No | 4 | A | Direct | |
Common Stock | Disposition | 2010-04-01 | 250 | $5.48 | 53,400 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 400 | $5.48 | 53,000 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 1,300 | $5.49 | 51,700 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 2,100 | $5.49 | 49,600 | No | 4 | W | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | W | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2010-04-01 | 60,000 | $0.00 | 60,000 | $5.49 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
60,000 | 2017-04-01 | No | 4 | A | Direct |
Footnotes
- Restricted Stock which vests in four equal annual installments beginning on April 1, 2011.
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
- This Option will become exercisable in four equal annual installments beginning on April 1, 2011.